| Literature DB >> 30364046 |
Álvaro Murillo-García1, Santos Villafaina1, José C Adsuar1, Narcis Gusi1, Daniel Collado-Mateo1,2.
Abstract
OBJECTIVE: The aim of this study was to perform a systematic review on the effectiveness of dance-based programs in patients with fibromyalgia, as well as calculate the overall effect size of the improvements, through a meta-analysis.Entities:
Year: 2018 PMID: 30364046 PMCID: PMC6188768 DOI: 10.1155/2018/8709748
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Study flow diagram.
Risk of bias and level of evidence.
|
| External | Internal | Statistics | PEDro Score | Level of Evidence | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ||
|
| |||||||||||||
|
| ✓ | ✓ | ✓ | ✓ | 3 | B | |||||||
|
| ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 8 | B | ||
|
| ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 5 | B | |||||
|
| ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 5 | B | |||||
|
| ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 5 | B | |||||
|
| ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 8 | B | ||
|
| ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 7 | B | |||
✓: criteria fulfilled; 1: the election criteria were specified; 2: the subjects were randomly assigned to the groups (in a cross-over study, the subjects were randomly distributed as they received the treatments); 3: the assignment was hidden; 4: the groups were similar at the beginning in relation to the most important prognostic indicator; 5: all subjects were blinded; 6: all the therapists who administered the therapy were blinded; 7: all evaluators who measured at least one key result were blinded; 8: the measurements of at least one of the key results were obtained from more than 85% of the subjects initially assigned to the groups; 9: results were presented for all subjects who received treatment or were assigned to the control group, or when this could not be, the data for at least one key result were analyzed by “intention to treat”; 10: the results of statistical comparisons between groups were informed for at least one key result; 11: the study provides punctual and variability measures for at least one key outcome; score: each criterion met (except the first) adds 1 point; B: level of evidence from randomized studies but without double blindness,
Characteristics of the sample and the protocol.
| Characteristics of the Sample | Protocol | |||
|---|---|---|---|---|
|
| Size (N) | Age (SD) | Control Group Treatment | Dance Based Group Treatment |
|
| 36∗ | 57 (7.20) | None | Dance Movement Therapy |
|
| ||||
|
| 36∗ | 57 (7.20) | None | Dance Movement Therapy |
|
| ||||
|
| 59∗ | 54.2 (6.2) EG | None | Biodance |
|
| ||||
|
| 39∗ | 55.41 (7.46) | Stretching exercise program: global and specific stretches of different muscle areas. | Biodance in a pool with a water temperature of 29°C, preceded by a shower at 33-35°C. |
|
| ||||
|
| 31∗ | 54.5 (7.5) EG | Multidisciplinary program based on: Pool exercises. Activity in the exercise room. Psychological-Educational Therapy. | Biodance |
|
| ||||
|
| 75∗ | 49.5 EG | None | Belly Dance |
|
| ||||
|
| 59∗ | 55.45 (7.80) EG | Stretching exercise program: Slow and coordinated breathing stretches. | Biodance in a pool with a water temperature of 29°C, preceded by a shower at 33-35°C. |
∗: n for the analysis of the effect of the treatment; ∗∗: n for the analysis of the intention to treat effect; EG: experimental group; CG: control group; N/A: not applicable; SD: standard deviation.
Duration and activities of the intervention.
|
| Intervention duration (weeks) | Session duration (minutes) | Weekly frequency (days) | Total time (hours) | Activities included in session |
|---|---|---|---|---|---|
|
| 24 | 60 | 1 | 24 | Exercises based on different themes: Body, space and group awareness. Expression and quality of movement. Movement about feelings, images and words. Differentiation of feelings and integration. Video interpretation. |
|
| |||||
|
| 24 | 60 | 1 | 24 | Exercises based on different themes: Body, space and group awareness. Expression and quality of movement. Movement about feelings, images and words. Differentiation of feelings and integration. |
|
| |||||
|
| 12 | 120 | 1 | 24 | 35-45 minutes, verbalization phase (information and experiences). 75-80 minutes, phase of dance movements according to the demands of the instructor and music, individually, in pairs and in groups. |
|
| |||||
|
| 12 | 60 | 2 | 24 | 10 minutes, warm-up and stretching. 40 minutes, biodance movements (walking or slow movements of limbs). 10 minutes, stretching. |
|
| |||||
|
| 16 | 120 | 1 | 32 | 35-45 minutes, verbalization phase (information and experiences). 75-80 minutes, phase of dance movements according to the demands of the instructor and music, individually, in pairs and in groups. |
|
| |||||
|
| 16 | 60 | 2 | 32 | Warm up exercises, movements of upper limbs, scapular area, trunk, hip, displacements (progression in difficulty). Exercises back to calm. CD at home to practice exercises. |
|
| |||||
|
| 12 | 60 | 2 | 24 | 10 minutes, flexibility and breathing. 40 minutes, basic movements of expression and creative dance including upper and lower members, according to music, expressing emotions generated by melodies, other people and interaction. All with cooperation between members. 10 minutes, relaxing exercises. |
Effects of dance interventions on pain.
|
| Instrument | Measurement range | Sample | Activity | CG | EG | P | Effect on CG | Effect on EG | Found Effect | Effect Size | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n CG | n EG | CG | EG | Mean Pre-T | SD | Mean Post-T | SD | Mean Pre-T | SD | Mean Post-T | SD | ||||||||
|
| VAS | 0-10 | 16 | 20 | None | DMT | NR | NR | NR | NR | NR | NR | NR | NR | D | ||||
|
| |||||||||||||||||||
|
| VAS | 0-10 | 16 | 20 | None | DMT | NR | NR | NR | NR | NR | NR | NR | NR | D | ||||
| Global Assessment of Well-being and Pain | 0-5 | 16 | 20 | None | DMT | NR | NR | NR | NR | NR | NR | NR | NR | A | |||||
|
| |||||||||||||||||||
|
| Algometer EFFEGI, FPK 20, Italy) | 0-90 | 32 | 27 | None | Biodance | 50.3 | 1.77 | 47.29 | 1.91 | 48.38 | 1.94 | 53.39 | 2.08 | A | -3.01 | 5.01 | 8.02 | 4.33 |
| Algometer EFFEGI, FPK 20, Italy) | 0-18 | 32 | 27 | None | Biodance | 16.16 | 0.38 | 16.38 | 0.46 | 16.77 | 0.42 | 15.32 | 0.5 | A | 0.22 | -1.45 | -1.67 | -4.18 | |
| FIQ | 0-10 | 32 | 27 | None | Biodance | 7.3 | 0.3 | 8 | 0.3 | 6.9 | 0.4 | 6.1 | 0.3 | AB | 0.7 | -0.8 | -1.5 | -4.29 | |
|
| |||||||||||||||||||
|
| VAS | 0-10 | 20 | 19 | Stretch. | Aquatic Biodance | 8.3 | 0.73 | 7.95 | 1.19 | 7.16 | 2.34 | 5.42 | 2.19 | B | -0.35 | -1.74 | -1.39 | -0.22 |
| Questionnaire McGill - Melzack | 0-78 | 20 | 19 | Stretch. | Aquatic Biodance | 39.7 | 8.31 | 35.25 | 4.88 | 39.58 | 3.3 | 28.68 | 6.69 | B | -4.45 | -10.9 | -6.45 | -0.22 | |
| Algometer Wagner FPI 10 – USA | 20 | 19 | Stretch. | Aquatic Biodance | |||||||||||||||
| FIQ | 0-10 | 20 | 19 | Stretch. | Aquatic Biodance | 7.07 | 1.8 | 6.69 | 1.75 | 7.2 | 1.68 | 5.33 | 2.12 | A | -0.38 | -1.87 | -1.49 | -0.28 | |
|
| |||||||||||||||||||
|
| Algometer (FPK 20; Effegi, Alfonsine, Italy) | 0-90 | 18 | 13 | Multid. | Biodance | 44.55 | 2.3 | 50.26 | 2.76 | 48.8 | 3.09 | 56.05 | 3.71 | D | 5.71 | 7.25 | 1.54 | 0.57 |
| Algometer (FPK 20; Effegi, Alfonsine, Italy) | 0-18 | 18 | 13 | Multid. | Biodance | 17.02 | 0.43 | 15.83 | 0.82 | 16.36 | 0.58 | 13.8 | 1.1 | D | -1.19 | -2.56 | -1.37 | -2.75 | |
| SF- 36 | 0-100 | 18 | 13 | Multid. | Biodance | 18.6 | 3 | 32.7 | 4.8 | 23.7 | 3.8 | 30 | 6.1 | D | 14.1 | 6.3 | -7.8 | -2.32 | |
| FIQ | 0-10 | 18 | 13 | Multid. | Biodance | 7.9 | 0.4 | 6.3 | 0.4 | 8.2 | 0.6 | 6.4 | 0.5 | D | -1.6 | -1.8 | -0.2 | -0.40 | |
|
| |||||||||||||||||||
|
| VAS | 0-10 | 37 | 38 | None | Belly Dance | 7.5 | 1.3 | 7.3 | 1.7 | 7.7 | 1.7 | 4.7 | 2.6 | A | -0.2 | -3 | -2.8 | -1.84 |
| SF-36 | 0-100 | 37 | 38 | None | Belly Dance | 25.7 | 13.4 | 29.1 | 21.1 | 29.6 | 17.5 | 46 | 19.2 | A | 3.4 | 16.4 | 13 | 0.83 | |
|
| |||||||||||||||||||
|
| VAS | 0-10 | 30 | 29 | Stretch. | Aquatic Biodance | 7.77 | 1.1 | 7.33 | 1.3 | 7.17 | 1.8 | 5.17 | 2.1 | AB | -0.44 | -2 | -1.56 | -0.27 |
| Questionnaire McGill - Melzack | 0-78 | 30 | 29 | Stretch. | Aquatic Biodance | 39.43 | 8.2 | 37.2 | 6.2 | 39.28 | 3.3 | 29.97 | 6.7 | AB | -2.23 | -9.31 | -7.08 | -0.25 | |
| Algometer Wagner FPI 10 – USA | 0-18 | 30 | 29 | Stretch. | Aquatic Biodance | 14.7 | 3.4 | 13.63 | 2.6 | 14.72 | 3.9 | 9.66 | 4.2 | AB | -1.07 | -5.06 | -3.99 | -0.36 | |
| FIQ | 0-10 | 30 | 29 | Stretch. | Aquatic Biodance | 7.7 | 1.2 | 7.8 | 1.1 | 6.93 | 1.9 | 5.45 | 1.8 | AB | 0.1 | -1.48 | -1.58 | -0.27 | |
EG: experimental group; CG: control group; n: sample size; SD: standard deviation T: test; P: P-value; VAS: visual analog scale; FIQ: fibromyalgia impact questionnaire; NR: not reported; N/A: not applicable; A: significant changes of experimental group versus control group; B: changes in experimental group; C: changes in group control; D: no significant changes; Multid.: multidisciplinary; Stretch.: stretching; DMT: Dance Movement Therapy.
Effects on other variables.
|
| Instrument | Measures | CG | EG | P. | Found Effect | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean Pre-T | SD | Mean Post-T | SD | Mean Pre-T | SD | Mean Post-T | SD | |||||
|
| Blood Samples | Dehydroepiandrosteronsulphate | NR | NR | NR | NR | NR | NR | NR | NR | D | |
| Blood Samples | Cortisol | NR | NR | NR | NR | NR | NR | NR | NR | D | ||
| Blood Samples | Prolactin | NR | NR | NR | NR | NR | NR | NR | NR | D | ||
| Blood Samples | Neuropeptide Y | NR | NR | NR | NR | NR | NR | NR | NR | D | ||
| Saliva Samples | Cortisol | NR | NR | NR | NR | NR | NR | NR | NR | D | ||
| Montgomery Asberg | Depression | NR | NR | NR | NR | NR | NR | NR | NR | D | ||
| Video-interpretation Rating Scale | Mobility | NR | NR | NR | NR | NR | NR | NR | NR | A | ||
| Video-interpretation Rating Scale | Perception of Movement Pain | NR | NR | NR | NR | NR | NR | NR | NR | A | ||
| Video-interpretation Rating Scale | Life Energy | NR | NR | NR | NR | NR | NR | NR | NR | A | ||
|
| ||||||||||||
|
| Self-Figure Drawing Procedure | Self-Image | ||||||||||
| Amount of Body Details | 11.9 | 1.9 | 8.9 | 1.9 | 11.1 | 1.9 | 16.1 | 1.9 | A | 8 | ||
| Amount of paper use in percent | 50 | 7.4 | 40 | 6.2 | 48.8 | 7.4 | 68.8 | 6.2 | A | 30 | ||
| Amount of Kilo Bytes when scanning | 136.8 | 6.9 | 135.5 | 12.1 | 148.4 | 6.9 | 156 | 12.1 | D | 8.9 | ||
| Amount of Colours | 3.5 | 0.6 | 3.3 | 0.6 | 3.3 | 0.6 | 3.8 | 0.6 | D | 0.7 | ||
| Comprehensive Psychopathologic Rating Scale | Depression | NR | NR | NR | NR | NR | NR | NR | NR | D | ||
| Sense of Coherence | Coping Capacity of Life-Stressors | NR | NR | NR | NR | NR | NR | NR | NR | D | ||
| Swedish Universities Scale of Personality | Personality Profile | NR | NR | NR | NR | NR | NR | NR | NR | D | ||
| Global Assessment of Well-Being and Pain | Well-Being | NR | NR | NR | NR | NR | NR | NR | NR | A | ||
|
| ||||||||||||
|
| Eight-Polar Tactile-Electrode Impedanciometer (InBody 720, Biospace) | Body Composition | ||||||||||
| Weight in Kilograms | 68.5 | 2.1 | 68.8 | 2 | 68.1 | 2.2 | 67.5 | 2.2 | D | -0.9 | ||
| Waist Circumference | 87.8 | 1.9 | 86.1 | 1.9 | 87.1 | 1.9 | 86.5 | 1.9 | D | 1.1 | ||
| Body Mass Index | 28.2 | 0.9 | 28.3 | 0.9 | 27.5 | 0.9 | 27.4 | 0.9 | D | -0.2 | ||
| Body Fat Percentage | 38.6 | 1.2 | 37.2 | 1.6 | 37.2 | 1.2 | 31.4 | 1.6 | AB | -4.4 | ||
| Muscle Mass in Kilograms | 22.6 | 0.5 | 22.7 | 1.4 | 23.3 | 0.5 | 27.2 | 1.5 | A | 3.8 | ||
| “30-Second Shair Stand” Test | Lower Body Muscular Strength | 7 | 0.5 | 8 | 0.5 | 8 | 0.5 | 10 | 0.5 | B | 1 | |
| Digital Dynamometer | Upper Body Muscular Strength | 15.7 | 1 | 17.3 | 1 | 18.1 | 1 | 18.4 | 1.1 | D | -1.3 | |
| “Chair Sit and Reach” Test | Lower Body Flexibility | -13.2 | 2.7 | -15.7 | 2.9 | -11 | 2.8 | -6.3 | 3 | D | 7.2 | |
| “Back Scratch” Test | Upper Body Flexibility | -7.3 | 2.4 | -9.3 | 2.4 | -6.5 | 2.4 | -5.8 | 2.5 | D | 2.7 | |
| “Blind Flamingo” Test | Static Balance | 10 | 1 | 11 | 1 | 10 | 1 | 9 | 1 | D | -2 | |
| “8-Feet Up and Go” Test | Motor Agility | 8.3 | 0.3 | 7.8 | 0.3 | 7.6 | 0.3 | 6.8 | 0.3 | B | -0.3 | |
| “6-Minute Walk” Test | Aerobic Endurance | 456.6 | 12.7 | 457 | 13.1 | 448.7 | 13.5 | 480.9 | 13.8 | A | 31.8 | |
| FIQ | Impact of the Syndrome | 0 | ||||||||||
| Physical Function | 4.3 | 0.3 | 4.8 | 0.4 | 4.4 | 0.4 | 3.6 | 0.4 | A | -1.3 | ||
| Fell-good | 8.3 | 0.4 | 8.8 | 0.4 | 7.6 | 0.4 | 6.1 | 0.5 | AB | -2 | ||
| Fatigue | 8.2 | 0.3 | 8.5 | 0.3 | 7.8 | 0.4 | 6.5 | 0.3 | AB | -1.6 | ||
| Morning Tiredness | 8 | 0.3 | 8.11 | 0.4 | 8.4 | 0.3 | 6.4 | 0.4 | A | -2.11 | ||
| Stiffness | 7.6 | 0.4 | 7.9 | 0.4 | 6.6 | 0.4 | 6 | 0.5 | B | -0.9 | ||
| Anxiety | 7.4 | 0.4 | 7.9 | 0.4 | 6.2 | 0.5 | 5.2 | 0.5 | AB | -1.5 | ||
| Depression | 6.1 | 0.5 | 7 | 0.5 | 5.7 | 0.6 | 4.9 | 0.6 | A | -1.7 | ||
| Final Score | 70.1 | 2.1 | 74 | 2.8 | 66.9 | 2.9 | 56 | 3.1 | AB | -14.8 | ||
| SF-36 | Health-related quality of Life | |||||||||||
| Physical Functioning | 39.1 | 3.5 | 38 | 3 | 38.1 | 3.8 | 44.8 | 3.2 | D | 7.8 | ||
| Physical Role | 5.2 | 3.3 | 3.3 | 2.6 | 6.8 | 3.6 | 10 | 2.8 | D | 5.1 | ||
| General Health | 26.5 | 3 | 29 | 3.1 | 33 | 3.2 | 35.6 | 3.4 | D | 0.1 | ||
| Vitality | 18.1 | 2.8 | 19 | 2.9 | 22.6 | 3 | 26.4 | 3.2 | D | 2.9 | ||
| Social Functioning | 44.4 | 4.4 | 36.7 | 3.7 | 49.2 | 4.8 | 55.6 | 4 | AB | 14.1 | ||
| Emotional Role | 33.4 | 8 | 38 | 8.1 | 39.4 | 8.8 | 48.8 | 8.9 | D | 4.8 | ||
| Mental Health | 45.4 | 3.6 | 44.9 | 4.2 | 50.8 | 3.9 | 57.9 | 4.6 | D | 7.6 | ||
| Hospital Anxiety and Depression Scale | Anxiety | 11.2 | 0.8 | 11 | 0.8 | 9.4 | 0.9 | 9.1 | 0.9 | D | -0.1 | |
| Depression | 9.3 | 0.7 | 9 | 0.8 | 7.5 | 0.8 | 7.3 | 0.9 | D | 0.1 | ||
| Vanderbilt Pain Management Inventory | Coping Strategies | |||||||||||
| Passive Coping | 24.7 | 0.8 | 24.2 | 0.7 | 23.2 | 0.9 | 20.7 | 0.7 | D | -2 | ||
| Active Coping | 16.1 | 0.7 | 16.1 | 0.7 | 16.5 | 0.7 | 16 | 0.7 | D | -0.5 | ||
| Rosenberg Self-Esteem Scale | Self-Esteem | 28.2 | 1.1 | 25.4 | 1.2 | 28.4 | 1.2 | 28.3 | 1.3 | A | 2.7 | |
| General Self-Efficacy Scale | Self-Efficacy | 25 | 1.3 | 25.5 | 1.3 | 26.9 | 1.4 | 27.9 | 1.4 | D | 0.5 | |
|
| ||||||||||||
|
| FIQ | Impact of the Syndrome | ||||||||||
| Daily Life Activities | 1.27 | 0.45 | 0.99 | 0.44 | 1.17 | 0.58 | 0.62 | 0.57 | A | -0.27 | ||
| Number of Days That Was Good the Last Week | 0.75 | 1.11 | 0.85 | 1.26 | 1.05 | 1.12 | 2.21 | 2.01 | A | 1.06 | ||
| Absent Days at Work | 0.92 | 1.55 | 0.84 | 1.67 | 1.1 | 2.07 | 0.55 | 1.66 | D | -0.47 | ||
| Fatigue | 7.85 | 1.18 | 7.45 | 1.39 | 7.95 | 1.35 | 6.31 | 1.85 | A | -1.24 | ||
| Morning Tiredness | 8.15 | 1.03 | 7.55 | 1.66 | 7.95 | 1.26 | 6.89 | 1.85 | D | -0.46 | ||
| Stiffness | 7.6 | 1.46 | 7.55 | 1.57 | 6.95 | 1.98 | 6.15 | 2 | A | -0.75 | ||
| Anxiety | 7.15 | 1.26 | 7.9 | 1.37 | 7.16 | 1.6 | 5.52 | 2.26 | A | -2.39 | ||
| Depression | 6.65 | 2 | 8.3 | 1.17 | 5.74 | 2.53 | 4.42 | 2.41 | A | -2.97 | ||
| Inconvenience on Work | 7.8 | 1.28 | 7.2 | 1.57 | 7.58 | 1.53 | 5.42 | 2.19 | A | -1.56 | ||
| Final Score | 69.55 | 12.96 | 69.23 | 12.89 | 67.08 | 10.51 | 52.16 | 16.18 | AB | -14.6 | ||
| Beck Inventory | Depression | 19.35 | 7.7 | 16.7 | 6.66 | 18.05 | 9.83 | 16.05 | 7.39 | D | 0.65 | |
|
| ||||||||||||
|
| Eight-Polar Tactile-Electrode Impedanciometer (InBody 720, Biospace) | Body Composition | ||||||||||
| Weight in Kilograms | 68.3 | 2.4 | 68.3 | 2.5 | 69 | 3.1 | 68 | 3.3 | D | -1 | ||
| Waist Circumference | 86.9 | 2.7 | 88.1 | 2.8 | 87.2 | 3.4 | 85.5 | 3.5 | D | -2.9 | ||
| Body Mass Index | 27.9 | 1.1 | 28 | 1.2 | 27.8 | 1.4 | 27.8 | 1.5 | D | -0.1 | ||
| Body Fat Percentage | 38.4 | 1.7 | 37.8 | 1.9 | 36.5 | 1.9 | 35.9 | 2.2 | D | 0 | ||
| Muscle Mass in Kilograms | 22.3 | 0.7 | 27.4 | 3.3 | 23.9 | 0.8 | 22.6 | 3.9 | D | -6.4 | ||
| “30-Second Chair Stand” Test | Lower Body Muscular Strength | 8 | 0.6 | 8.2 | 0.6 | 7.7 | 0.8 | 8.2 | 0.7 | D | 0.3 | |
| “Chair Sit and Reach” Test | Lower Body Flexibility | -17.6 | 4.5 | -7.7 | 2.9 | -15.7 | 5.8 | -6.9 | 3.7 | D | -1.1 | |
| “Back Scratch” Test | Upper Body Flexibility | -7.3 | 2.4 | -9.3 | 2.4 | -6.5 | 2.4 | -5.8 | 2.5 | D | 2.7 | |
| “8-Feet Up and Go” Test | Motor Agility | 8.1 | 0.4 | 7.9 | 0.4 | 7.8 | 0.5 | 6.6 | 0.5 | D | -1 | |
| “6-Minute Walk” Test | Aerobic Endurance | 449.6 | 16.3 | 445.8 | 14.6 | 443.9 | 20.3 | 461 | 18.1 | D | 20.9 | |
| Dinamómetro Digital | Upper Body Muscular Strength | 14.8 | 1.6 | 16.1 | 1.3 | 17.9 | 1.9 | 20.4 | 1.6 | D | 1.2 | |
| “Blind Flamingo” Test | Static Balance | 12.2 | 1.1 | 10.6 | 1.3 | 9.6 | 1.5 | 9.6 | 1.7 | D | 1.6 | |
| FIQ | Impact of the Syndrome | |||||||||||
| Physical Function | 5.4 | 0.5 | 4 | 0.5 | 4.4 | 0.6 | 4.3 | 0.7 | D | 1.3 | ||
| Well-Being | 8.7 | 0.5 | 7.8 | 0.7 | 8.6 | 0.6 | 6.7 | 0.8 | D | -1 | ||
| Fatigue | 8.5 | 0.4 | 7.6 | 0.5 | 8.4 | 0.6 | 7.7 | 0.6 | D | 0.2 | ||
| Morning Tiredness | 8.3 | 0.4 | 8.1 | 0.4 | 8.9 | 0.6 | 8.3 | 0.6 | D | -0.4 | ||
| Stiffness | 7.6 | 0.5 | 6.1 | 0.6 | 8.3 | 0.7 | 7 | 0.8 | D | 0.2 | ||
| Anxiety | 8.5 | 0.4 | 5.9 | 0.6 | 7.7 | 0.5 | 6.9 | 0.8 | D | 1.8 | ||
| Depression | 7 | 0.7 | 4.9 | 0.7 | 7.8 | 0.9 | 6.3 | 0.9 | D | 0.6 | ||
| Final Score | 74.6 | 3.1 | 62.9 | 3.7 | 77.7 | 3.9 | 64.9 | 4.7 | BC | -1.1 | ||
| SF-36 | Health-related quality of Life | |||||||||||
| Physical Functioning | 35.8 | 4.7 | 42.4 | 4.8 | 35 | 6 | 38.3 | 6.2 | D | -3.3 | ||
| Physical Role | 0 | 0 | 9.7 | 4.6 | 9.1 | 5.6 | 4.5 | 5.9 | A | -14.3 | ||
| General Health | 27.7 | 3.2 | 31.9 | 3.3 | 26 | 4 | 31.9 | 4.2 | D | 1.7 | ||
| Vitality | 20.4 | 4 | 23.5 | 3.5 | 16.2 | 2.1 | 25.2 | 4.5 | D | 5.9 | ||
| Social Functioning | 31.7 | 6.1 | 51.6 | 5.8 | 44.3 | 7.8 | 43.9 | 7.5 | A | -20.3 | ||
| Emotional Role | 25.5 | 8.5 | 42.7 | 10.3 | 15.8 | 10.8 | 12 | 13.2 | D | -21 | ||
| Mental Health | 41.7 | 4.5 | 53.3 | 4.6 | 37.3 | 5.8 | 44 | 5.9 | D | -4.9 | ||
| Hospital Anxiety and Depression Scale | Anxiety | 11.9 | 1 | 10.4 | 1 | 12.1 | 1.3 | 11.9 | 1.3 | D | 1.3 | |
| Depression | 9.6 | 1.1 | 8.5 | 1 | 9.1 | 1.4 | 8.5 | 1.3 | D | 0.5 | ||
| Vanderbilt Pain Management Inventory | Coping Strategies | |||||||||||
| Passive Coping | 25.6 | 0.7 | 21.4 | 0.9 | 23.7 | 0.9 | 22.2 | 1.2 | A | 2.7 | ||
| Active Coping | 15.6 | 0.9 | 17 | 0.9 | 15.9 | 1.1 | 14.2 | 1.1 | D | -3.1 | ||
| Rosenberg Self-Esteem Scale | Self-Esteem | 29.1 | 1.4 | 29.2 | 1.3 | 26.4 | 1.2 | 27.1 | 1.7 | D | 0.6 | |
| General Self-Efficacy Scale | Self-Efficacy | 26.1 | 1.9 | 27.1 | 1.5 | 24.1 | 2.4 | 23.1 | 1.9 | D | -2 | |
|
| ||||||||||||
|
| “6-Minute Walk” Test | Functional Capacity | 332 | 66.7 | 343 | 77.9 | 372.8 | 80.2 | 431 | 88.7 | A | 47.2 |
| FIQ | Impact of the Syndrome | 6.34 | 1.29 | 5.9 | 1.86 | 5.89 | 1.39 | 4.26 | 1.81 | A | -1.19 | |
| SF-36 | Health-related quality of Life | |||||||||||
| Physical Functioning | 32.6 | 18.9 | 39.1 | 22 | 44.9 | 1.89 | 56.3 | 19.9 | D | 4.9 | ||
| Physical Role | 8.8 | 17.9 | 13.8 | 26.5 | 24.7 | 32.2 | 36.5 | 32.4 | D | 6.8 | ||
| General Health | 38 | 16.5 | 41.5 | 21.4 | 46 | 21.7 | 44.9 | 15.6 | D | -4.6 | ||
| Vitality | 29 | 18.2 | 37.1 | 21.8 | 41.3 | 18.8 | 47.6 | 23.8 | D | -1.8 | ||
| Social Functioning | 47.6 | 23.1 | 51.3 | 25.5 | 52.6 | 27.7 | 57.2 | 27 | D | 0.9 | ||
| Emotional Role | 21.2 | 33.1 | 31.5 | 38.7 | 34.2 | 36.9 | 51.9 | 39.6 | A | 7.4 | ||
| Mental Health | 43.4 | 24 | 46.2 | 22.6 | 46 | 19.9 | 52.3 | 20.8 | A | 3.5 | ||
| Beck Inventory | Depression | 21.2 | 13 | 23.5 | 13.7 | 23.9 | 14.7 | 23.1 | 15.3 | D | -3.1 | |
| State-Trait Anxiety Inventory, Part 1 | Anxiety | 52.8 | 8.1 | 51.8 | 9.4 | 50.5 | 7.68 | 49.4 | 10 | D | -0.1 | |
| State-Trait Anxiety Inventory, Part 2 | Anxiety | 53 | 9.7 | 54.1 | 10.1 | 51.1 | 7.8 | 49.8 | 9.1 | D | -2.4 | |
| Body Dysmorphic | Self-Image | 48.8 | 34.2 | 46.9 | 31.8 | 42.8 | 32.6 | 41.1 | 24.24 | A | 0.2 | |
|
| ||||||||||||
|
| FIQ | Impact of the Syndrome | ||||||||||
| Daily Life Activities | 1.28 | 0.4 | 1.4 | 0.5 | 1.12 | 0.5 | 0.65 | 0.6 | AB | -0.59 | ||
| Number of Days That Was Good the Last Week | 0.9 | 1.2 | 1 | 1.3 | 1 | 1.1 | 2.07 | 2.1 | AB | 0.97 | ||
| Absent Days at Work | 1.33 | 1.6 | 1.22 | 1.8 | 0.73 | 1.7 | 0.38 | 1.3 | D | -0.24 | ||
| Fatigue | 6.89 | 1.6 | 6.56 | 1.5 | 6.87 | 1.8 | 4.46 | 2.4 | AB | -2.08 | ||
| Morning Tiredness | 7.77 | 1.3 | 7.57 | 1.2 | 7.59 | 1.3 | 6.66 | 1.9 | D | -0.73 | ||
| Stiffness | 7.8 | 1.1 | 7.53 | 1.5 | 7.59 | 1.3 | 7.17 | 2 | D | -0.15 | ||
| Anxiety | 7.03 | 1.5 | 6.47 | 1.7 | 6.86 | 1.8 | 6.41 | 1.9 | D | 0.11 | ||
| Depression | 7.1 | 1.3 | 6.97 | 1.2 | 7.03 | 1.5 | 5.9 | 2.5 | AB | -1 | ||
| Inconvenience on Work | 6.53 | 1.9 | 6.4 | 1.7 | 5.66 | 2.5 | 4.52 | 2.4 | D | -1.01 | ||
| Final Score | 68.63 | 14.1 | 68.5 | 14.1 | 65.79 | 11.2 | 53.73 | 18 | AB | -11.95 | ||
| Pittsburgh Sleep | Sleep Quality | 14.7 | 2.4 | 14.4 | 2.4 | 15.1 | 1.7 | 7.59 | 1.8 | AB | -7.21 | |
| Center for Epidemiologic | Depression | 26.37 | 6.4 | 27.7 | 7.3 | 23.07 | 9.7 | 20.41 | 11.1 | D | -3.99 | |
| State Anxiety Inventory | Anxiety | 44.97 | 4.5 | 44.87 | 5.1 | 45.17 | 3.9 | 38.79 | 5.8 | AB | -6.28 | |
EG: experimental group; CG: control group; n: sample size; SD: standard deviation; T: test; FIQ: Fibromyalgia Impact Questionnaire; NR: not reported; NA: not applicable; A: significant changes of experimental group versus control group; B: changes in experimental group; C: changes in control group; D: not significative changes; P: P-value.
Figure 2Effect sizes for pain of the articles included in the meta-analysis.